Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom

The novel coronavirus 2 (SARS-CoV-2) was first described in Wuhan, China, in December 2019, and causes the infectious disease; COVID-19, which has been declared a pandemic by the World Health Organization. COVID-19 pneumonia may lead to acute respiratory distress syndrome and severe respiratory failure [1]. Other complications include myocarditis, renal failure and neurological involvement [2].

Source: Thrombosis Research - May 27, 2020 Category: Hematology Authors: Michael J.R. Desborough, Andrew J. Doyle, Alexandra Griffiths, Andrew Retter, Karen A. Breen, Beverley J. Hunt Tags: Letter to the Editors-in-Chief Source Type: research